EFSPI-BBS joint European Statistical Meeting on Oncology : Summary by Pierre Verweij and Egbert Biesheuvel
European Statistical Meeting on Oncology - Agenda
Introduction - Challenges in development in Oncology - H.U. Burger (Hoffmann-La Roche)
A Case Study: Intra-patient Dose Escalation - Jonas Wiedemann (F. Hoffmann-La Roche)
Understanding Progression-free Survival - Bertil Jonsen (Medical Products Agency)
Optimal cost-effective Go-No Go decisions - Cong Chen (Merck & Co)
The time to progression ratio for phase II trials of personalized medicine - Marc Buyse (IDDI)
IRESSA: A journey of experience from broad to biomarker populations - Claire Watkins (AstraZeneca)